Table 5.
Cox regression of mRNA expression in metastasis of breast cancer.
| Variable | B | SE | Wald | P-value | OR | OR 95% CI | |
|---|---|---|---|---|---|---|---|
| ER | − 0.194 | 0.217 | 0.799 | 0.372 | 0.823 | 0.538 | 1.261 |
| HER2 | − 0.338 | 0.228 | 2.204 | 0.138 | 0.713 | 0.456 | 1.114 |
| E-Cad | − 0.163 | 0.363 | 0.203 | 0.653 | 0.849 | 0.417 | 1.729 |
| Ki67 | 0.114 | 0.270 | 0.180 | 0.671 | 1.121 | 0.661 | 1.903 |
| Molecular subtypes | |||||||
| Luminal A | – | – | – | – | Reference | Reference | Reference |
| Luminal B | 0.123 | 0.567 | 0.047 | 0.828 | 1.131 | 0.372 | 3.44 |
| Luminal HER2 | 0.144 | 0.633 | 0.052 | 0.82 | 1.155 | 0.334 | 3.992 |
| HER2-enriched | − 0.016 | 0.698 | 0.001 | 0.982 | 0.984 | 0.251 | 3.863 |
| Basal-like | − 0.338 | 0.228 | 2.204 | 0.138 | 0.713 | 0.456 | 1.114 |
| Lymph node metastasis | |||||||
| 0 | – | – | – | – | Reference | Reference | Reference |
| 1 ~ 3 | 0.149 | 0.335 | 0.198 | 0.656 | 1.161 | 0.602 | 2.238 |
| 4 ~ 9 | 0.702 | 0.307 | 5.208 | 0.022 | 2.017 | 1.104 | 3.685 |
| ≥ 10 | 1.116 | 0.280 | 15.886 | < 0.001 | 3.053 | 1.763 | 5.286 |
| MSH2 | 0.027 | 0.008 | 11.605 | 0.001 | 1.027 | 1.012 | 1.044 |
| MLH1 | − 2.723 | 1.019 | 7.146 | 0.008 | 0.066 | 0.009 | 0.484 |
| PARP1 | 0.051 | 0.013 | 15.462 | < 0.001 | 1.052 | 1.026 | 1.080 |
| XRCC1 | − 0.004 | 0.006 | 0.439 | 0.508 | 0.996 | 0.985 | 1.008 |
| XRCC4 | − 0.053 | 0.033 | 2.545 | 0.111 | 0.949 | 0.889 | 1.012 |
| 53BP1 | − 0.383 | 0.891 | 0.185 | 0.667 | 0.682 | 0.119 | 3.905 |
| ERCC1 | 0.033 | 0.031 | 1.106 | 0.293 | 1.033 | 0.972 | 1.099 |
| XPA | − 0.090 | 0.080 | 1.247 | 0.264 | 0.914 | 0.781 | 1.070 |